Oppenheimer Maintains Perform on Boston Scientific, Raises Price Target to $59
Portfolio Pulse from Benzinga Newsdesk
Oppenheimer analyst Steven Lichtman maintains a 'Perform' rating on Boston Scientific (NYSE:BSX) and raises the price target from $58 to $59.
July 28, 2023 | 12:07 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Oppenheimer maintains a 'Perform' rating on Boston Scientific and raises the price target to $59.
The raised price target by Oppenheimer indicates a positive outlook for Boston Scientific. This could potentially lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100